期刊文献+

8-MOP、ATRA以及二者联合应用对Mc3细胞克隆形成的影响 被引量:4

Effects of: 8-M0P or/and ATRA on Mc3 Cell Clonogenicity
暂未订购
导出
摘要 研究8-MOP与ATRA单独及联合应用对Mc3细胞克隆的影响。方法。软琼脂克隆法。结果:照组细胞克隆形成率为53.1%,经IC308-MOP与ATRA单独及联合作用5-d以后,克隆形成率降低为8-MOP组0.9%,ATRA组35.1%,联合用药组3.2%。结论:8-MOP与ATRA单独及联合应用Mc3细胞克隆形成率降低,有可能使Mc3细胞的转移能力下降。 To study the effects of 8-MOP or/and ATRA on Mc3 cell clonogenicity.Methods: The clonogenicity of Mc3 cells was as-sayed by clonogenic assay after the cells had beenfreated with 8-MOP,ATRA or 8-MOP with A-TRA at the dosage 0f IC30 Results: The clono-genicity of the cells was 53%, 0. 9%,35. 1%,and3. 2% for control, 8-MOP, ATRA and 8-MOPwith ATRA treated cells respectively. Conclu-sion: 8-MOP or/and ATRA may inhibit clono-genicity of Mc3 cells.
出处 《实用口腔医学杂志》 CAS CSCD 北大核心 1999年第6期465-466,共2页 Journal of Practical Stomatology
基金 国家自然科学基金!39370740
关键词 甲氧沙林 维甲酸 粘液表皮样癌 克隆集落形成测定 Methoxsalen Tretinoin Mucoepidermoid carcinoma Colony forming units assay
  • 相关文献

参考文献1

二级参考文献5

共引文献27

同被引文献25

  • 1Nakayama H, Yasui W, Yokozaki H, et al. Reduced expression of nm23 is associated with metastasis of human gastric carcinomas.Jpn J Cancer Res,1993,84: 184 - 190.
  • 2Hohaus S, Cavallo S, Bellacosa A, et al. Telomerase in human laryngeal squamous cell carcinoma. Clin Cancer Res, 1996,2 ( 11 ): 1895-1900.
  • 3Roth RM, Takamori Y, LochmannER. Thiopyronine and 8 -methoxypaoralen - sensitized phatadynamic effect on cell growth, colony formy ability and RNA synthesis in sacchtomyces mutants deficient in DNA repair. Photobiol, 1994,59 (6) : 627.
  • 4Greenberg RA, O' Hagan RC, Deng H, et al. Telomerase reverse transcriptase gene is a direct target of c - myc ,but is not functionally equivalent in cellular transformation. Oncogene, 1999,18 ( 5 ): 1219-1 226.
  • 5Xie WF, Lin Y, Zhang ZB, et al. Regulation of telomerase activity by recombinatant human tumor necrosis factor in vitro. World J Gastroenterol,2000,6 ( suppl 3) : 37.
  • 6Terashima M, Takiyama I, Uesugi N, et al. Telomerase assay as a possible predictor of the response to anticancer chemotherapy. Anticancer Res,2000,20 (1A) : 293 -237.
  • 7Dhaene K,Van Marck E,Pan aresch R.Telomeres.telomerase and cancer:An up date.Virchows Arch,2000,437(1):1.
  • 8Kim NW,Wu F.Advances in quantification and characterization of telomerase activity by the telomeric repeat amplification protocol(TRAP).Nucleic Acide Res,1997,25(6):2595.
  • 9Zhu X,Kumar R,Mandal M,et al.Cell cycle-dependent modulation of telomerase activity in tumor cells.Proc Natl Acad Sci USA, 1996,93(12): 6091.
  • 10Terashima M, Takiyama I, Uesugi N,et al.Telomerase assay as a possible predictor of the response to anticancer chemotherapy.Anticancer Res, 2000,20(1A):293.?A

引证文献4

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部